Atlas Trials

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Clinical trial NCT04604899 · COMPLETED

Trial details

NCT number
NCT04604899
Sponsor
jCyte, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2020-12-01
Primary completion
2022-03-22
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.